The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Verona Pharma plc(NASDAQ:VRNA) 
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. Its product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 ...
Website: http://www.veronapharma.com
Founded: 2005
Full Time Employees: 33
Sector: Healthcare
Industry: Biotechnology
Verona Pharma plc Days Payable Outstanding ttm (DPO)
Verona Pharma plc Days Receivable Outstanding ttm (DSO)
Verona Pharma plc Days Inventory Outstanding ttm (DIO)
Verona Pharma plc Op Cashflow Per Share ttm
Verona Pharma plc Free Cashflow Per Share ttm
Verona Pharma plc Cash Per Share ttm
Verona Pharma plc P/S ratio ttm
Verona Pharma plc (GAAP) P/E ratio ttm
Verona Pharma plc P/B ratio ttm
No extra charts and metrics for this ticker.